TYK Medicines, Inc (Stock Code: 2410) Granted Drug Manufacturing License

Bulletin Express

01/23

TYK Medicines, Inc (浙江同源康醫藥股份有限公司) (Stock Code: 2410) announced that it has been granted the Drug Manufacturing License by the Drug Administration of Zhejiang Province. According to the announcement, the license carries the number “Zhejiang 20260002” and remains valid until January 22, 2031. The production address and range designate Asymchem Life Science (Tianjin) Co., Ltd. as trustee manufacturer at No. 71, 7th Street, Economic-Technological Development Area, Tianjin.

The announcement indicates that securing this license may facilitate the company’s capacity and market expansion, laying a foundation for subsequent commercial production of cancer-treatment products. Caution is noted under Rule 18A.05 of the Listing Rules, reminding shareholders and potential investors that there is no assurance the relevant product will ultimately be successfully developed or marketed.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1156381147"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1156381147\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1156381147?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-23 19:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156381147","market":"hk","top_or_hot":-1,"title":"TYK Medicines, Inc (Stock Code: 2410) Granted Drug Manufacturing License","media":"Bulletin Express","content":"<p>TYK Medicines, Inc (浙江同源康醫藥股份有限公司) (Stock Code: 2410) announced that it has been granted the Drug Manufacturing License by the Drug Administration of Zhejiang Province. According to the announcement, the license carries the number “Zhejiang 20260002” and remains valid until January 22, 2031. The production address and range designate Asymchem Life Science (Tianjin) Co., Ltd. as trustee manufacturer at No. 71, 7th Street, Economic-Technological Development Area, Tianjin.</p>\n<p>The announcement indicates that securing this license may facilitate the company’s capacity and market expansion, laying a foundation for subsequent commercial production of cancer-treatment products. Caution is noted under Rule 18A.05 of the Listing Rules, reminding shareholders and potential investors that there is no assurance the relevant product will ultimately be successfully developed or marketed.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TYK Medicines, Inc (Stock Code: 2410) Granted Drug Manufacturing License</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTYK Medicines, Inc (Stock Code: 2410) Granted Drug Manufacturing License\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-01-23 19:44</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>TYK Medicines, Inc (浙江同源康醫藥股份有限公司) (Stock Code: 2410) announced that it has been granted the Drug Manufacturing License by the Drug Administration of Zhejiang Province. According to the announcement, the license carries the number “Zhejiang 20260002” and remains valid until January 22, 2031. The production address and range designate Asymchem Life Science (Tianjin) Co., Ltd. as trustee manufacturer at No. 71, 7th Street, Economic-Technological Development Area, Tianjin.</p>\n<p>The announcement indicates that securing this license may facilitate the company’s capacity and market expansion, laying a foundation for subsequent commercial production of cancer-treatment products. Caution is noted under Rule 18A.05 of the Listing Rules, reminding shareholders and potential investors that there is no assurance the relevant product will ultimately be successfully developed or marketed.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02410","symbol_name":"同源康醫藥-B","start_time":0,"source_url":"","article_id":"1156381147","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156381147","pubTimestamp":1769168676,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"TYK Medicines, Inc (浙江同源康醫藥股份有限公司) (Stock Code: 2410) announced that it has been granted the Drug Manufacturing License by the Drug Administration of Zhejiang Province. According to the announcement,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02410":"同源康医药-B"},"translate_title":"TYK Medicines，Inc（股份代号：2410）获授药品生产许可证","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02410":1},"content_text":"TYK Medicines, Inc (浙江同源康醫藥股份有限公司) (Stock Code: 2410) announced that it has been granted the Drug Manufacturing License by the Drug Administration of Zhejiang Province. According to the announcement, the license carries the number 「Zhejiang 20260002」 and remains valid until January 22, 2031. The production address and range designate Asymchem Life Science (Tianjin) Co., Ltd. as trustee manufacturer at No. 71, 7th Street, Economic-Technological Development Area, Tianjin.\nThe announcement indicates that securing this license may facilitate the company’s capacity and market expansion, laying a foundation for subsequent commercial production of cancer-treatment products. Caution is noted under Rule 18A.05 of the Listing Rules, reminding shareholders and potential investors that there is no assurance the relevant product will ultimately be successfully developed or marketed.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}